This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

EU regulator opens in-depth probe into Zimmer’s acquisition of Biomet

( October 3, 2014, 14:00 GMT | Official Statement) -- MLex Summary: The European Commission has started an in-depth investigation into plans by US orthopedic-device maker Zimmer Holdings to acquire rival Biomet, on concerns that the deal might lead to less innovation and choice as well as increased prices for orthopedic implants and related surgical products. The deadline for the conclusion of the review is Feb. 16, 2015.Full statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login